AATK Inhibitors
The chemical class known as AATK inhibitors encompasses compounds that can modulate the function of the apoptosis-associated tyrosine kinase, either directly by binding to the protein and inhibiting its kinase activity or indirectly by affecting the signaling pathways where AATK is a critical component. Since there are no well-characterized direct inhibitors of AATK, the focus is on indirect inhibitors that target signaling pathways implicated in AATK's regulation of cell differentiation, survival, and apoptosis.
AATK inhibitors are instrumental in dissecting the PI3K/Akt pathway, which is a pivotal signaling cascade influencing various cellular outcomes including those associated with AATK activity. The inhibition of PI3K by these compounds can result in decreased Akt activity, leading to an increase in pro-apoptotic signaling that might be under theregulatory influence of AATK. Similarly, U0126 and PD98059 are selective for MEK1/2 and impede the MAPK/ERK pathway, which has been shown to regulate AATK expression and activity, thereby indirectly affecting AATK's role in processes like neuronal differentiation. On the other hand, inhibitors such as SB203580, SP600125, and Staurosporine target various MAPKs, which are involved in transmitting apoptosis and differentiation signals within the cell. By modulating the activity of these kinases, these inhibitors can affect the regulatory role of AATK in apoptosis. Inhibitors also indirectly influence AATK activity due to the complex interplay between different tyrosine kinases within cellular signaling networks. Genistein and Lavendustin A, as broad-spectrum tyrosine kinase inhibitors, can disrupt kinase-dependent signaling processes, potentially affecting AATK functions indirectly.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which can regulate AATK through the PI3K/Akt pathway by influencing cell survival signals that may indirectly affect AATK's role in apoptosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that impairs the PI3K signaling cascade, potentially altering the phosphorylation and activation states of downstream targets including AATK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAPK. Since p38 MAPK can influence apoptosis and cell differentiation, SB203580 can indirectly modulate AATK activity by affecting these cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which is part of the MAPK signaling pathways. JNK can modulate apoptotic signals that could interact with AATK's functions, and SP600125 can therefore indirectly affect AATK's role in apoptosis. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A tyrosine kinase inhibitor that primarily targets BCR-ABL and SRC family kinases. As AATK is a tyrosine kinase, dasatinib can indirectly affect AATK activity through complex kinase signaling networks. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that acts as a tyrosine kinase inhibitor. It can interfere with various kinases, potentially altering the phosphorylation states that could indirectly influence AATK's function in cell signaling pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A selective inhibitor of Src family tyrosine kinases. As AATK has tyrosine kinase activity, PP2 may modulate related signaling pathways and thereby affect AATK's function in neuronal apoptosis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, which acts upstream of the ERK pathway. By inhibiting MEK, PD98059 can indirectly influence AATK activity associated with the ERK signaling pathway and its effects on cell differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can influence cellular growth and apoptosis pathways that are potentially linked to AATK activity. Through its action on mTOR, rapamycin can affect the signaling pathways that modulate AATK functions. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor with a broad spectrum. It inhibits protein kinase C (PKC) and other kinases, which can indirectly influence AATK's activity within the complex network of cell signaling involving apoptosis. | ||||||